MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
W. Ray Kim(Mayo Clinic in Arizona), Allison J. Kwong(Stanford University), Scott W. Biggins(University of Colorado Denver), Sommer E. Gentry(United States Naval Academy), Julie K. Heimbach(Mayo Clinic in Arizona), Nicholas L. Wood(United States Naval Academy), Sumeet K. Asrani(Baylor University Medical Center), Ajitha Mannalithara(Stanford University), Patrick S. Kamath(Mayo Clinic in Arizona)
Cited by 583
Related Papers
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.1k
Global burden of liver disease: 2023 update
|Journal of Hepatology|2023|1.9k
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
|New England Journal of Medicine|2008|1.5k